[EN] HIV INHIBITING 1,2,4-TRIAZInONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,2,4-TRIAZINONE INHIBITEURS DU VIH
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006015985A1
公开(公告)日:2006-02-16
The present invention relates to HIV replication inhibitors of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; optionally substituted C1-6alkyl; C1-6alkyloxy C1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
The present invention relates to HIV replication inhibitors of formula
a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R
1
represents hydrogen; aryl; formyl; C
1-6
alkylcarbonyl; C
1-6
alkyloxycarbonyl; optionally substituted C
1-6
alkyl; C
1-6
alkyloxyC
1-6
alkylcarbonyl substituted with C
1-6
alkyloxycarbonyl; R
2
or R
4
represents hydrogen; hydroxy; halo; optionally substituted C
1-6
alkyl; optionally substituted C
2-6
alkenyl; optionally substituted C
2-6
alkynyl; C
3-7
cycloalkyl; C
1-6
alkyloxy; C
1-6
alkyloxycarbonyl; C
1-6
alkylcarbonyloxy; carboxyl; cyano; nitro; amino; mono- or di(C
1-6
alkyl)amino; polyhaloC
1-4
alkyl; polyhaloC
1-4
alkyloxy; polyhaloC
1-4
alkylthio; —S(═O)
p
R
6
; —NH—S(═O)
p
R
6
; —C(═O)R
6
; —NHC(═O)H; —C(═O)NHNH
2
; NHC(═O)R
6
; C(═NH)R
6
; or R
7
; R
2a
or R
3
represents cyano; aminocarbonyl; amino; halo; NHR
13
; NR
13
R
14
—C(═O)—NHR
13
; —C(═O)—NR
13
R
14
; —C(═O)—R
15
; —CH═N—NH—C(═O)—R
16
; optionally substituted C
1-6
alkyl; optionally substituted C
1-6
alkyloxy; optionally substituted C
1-6
alkyloxyC
1-6
alkyl; optionally substituted C
2-6
alkenyl; optionally substituted C
2-6
alkynyl; —C(═N—O—R
8
)—C
1-4
alkyl; R
7
or —X
3
—R
7
; X
1
or X
2
represents —NR
1
—; —NH—NH—; —N═N—; —O—; —C(═O)—; —C
1-4
alkanediyl-; —CHOH—; —S—; —S(═O)
p
—; —X
4
—C
1-4
alkanediyl-; —C
1-4
alkanediyl-X
4
—; or —C
1-4
alkanediyl-X
4
—C
1-4
alkanediyl-; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.